201 related articles for article (PubMed ID: 17699742)
1. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
[TBL] [Abstract][Full Text] [Related]
2. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
3. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
4. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
5. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
[TBL] [Abstract][Full Text] [Related]
7. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
8. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
[TBL] [Abstract][Full Text] [Related]
10. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
[TBL] [Abstract][Full Text] [Related]
11. No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
Tonino SH; Spijker R; Luijks DM; van Oers MH; Kater AP
Blood; 2008 Aug; 112(3):840-3. PubMed ID: 18519815
[TBL] [Abstract][Full Text] [Related]
12. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.
Messmer D; Fecteau JF; O'Hayre M; Bharati IS; Handel TM; Kipps TJ
Blood; 2011 Jan; 117(3):882-9. PubMed ID: 21079155
[TBL] [Abstract][Full Text] [Related]
15. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
[TBL] [Abstract][Full Text] [Related]
16. CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells.
Deaglio S; Aydin S; Grand MM; Vaisitti T; Bergui L; D'Arena G; Chiorino G; Malavasi F
Mol Med; 2010 Mar; 16(3-4):87-91. PubMed ID: 19956559
[TBL] [Abstract][Full Text] [Related]
17. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
Gupta R; Garg N; Singh A; Jain SL
Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
[TBL] [Abstract][Full Text] [Related]
18. CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.
Hayat A; O'Brien D; O'Rourke P; McGuckin S; Fitzgerald T; Conneally E; Browne PV; McCann SR; Lawler MP; Vandenberghe E
Leuk Lymphoma; 2006 Nov; 47(11):2371-9. PubMed ID: 17107912
[TBL] [Abstract][Full Text] [Related]
19. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
20. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]